Stockscreener 앱 받기
1.09
0.00%
0.00
시장 영업 전:
1.12
0.03
+2.75%
전일 마감가:
$1.09
열려 있는:
$1.08
하루 거래량:
388.19K
Relative Volume:
0.98
시가총액:
$42.12M
수익:
$40.93M
순이익/손실:
$-15.57M
주가수익비율:
-2.9277
EPS:
-0.3723
순현금흐름:
$-17.84M
1주 성능:
+4.81%
1개월 성능:
+37.63%
6개월 성능:
+22.47%
1년 성능:
-64.38%
1일 변동 폭
$1.04
$1.09
1주일 범위
$0.96
$1.09
52주 변동 폭
$0.605
$3.08
Myomo Inc Stock (MYO) Company Profile
명칭
Myomo Inc
전화
617-996-9058
주소
One Broadway, 14th Floor, Cambridge, MA
Compare MYO vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
1.09 | 42.12M | 40.93M | -15.57M | -17.84M | -0.3723 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-31 | 개시 | Craig Hallum | Buy |
| 2024-05-20 | 개시 | Lake Street | Buy |
| 2023-12-15 | 개시 | H.C. Wainwright | Buy |
| 2020-11-11 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2020-05-27 | 개시 | Dougherty & Company | Buy |
| 2017-10-02 | 개시 | H.C. Wainwright | Buy |
모두보기
Myomo Inc 주식(MYO)의 최신 뉴스
Myomo (MYO) director buys 25K open-market shares of Common Stock - Stock Titan
Myomo (MYO) shows fast-paced momentum but is still a bargain stock - MSN
Myomo (MYO) Insider Trading Activity 2026 $MYO - MarketBeat
Insider Sell Alert: Harry Kovelman Sells 32,000 Shares of Myomo Inc (MYO) - GuruFocus
Myomo CMO Kovelman sells $32,239 in company stock - Investing.com
MYOMO (MYO) Chief Medical Officer sells 32,000 shares in open-market trades - Stock Titan
Myomo CMO Kovelman sells $32,239 in company stock By Investing.com - Investing.com UK
Myomo (MYO) Shows Fast-paced Momentum But Is Still a Bargain Stock - Yahoo Finance
MYO (NYSE) affiliate lists multiple restricted stock sales on Form 144 - Stock Titan
Rule 144 Notice: MYO (NYSE) — 11,536 Common Shares Listed for Sale - Stock Titan
Myomo, Inc. (MYO) reports Q1 loss, beats revenue estimates - MSN
MYO: Wearable robotics drive growth with expanding reimbursement and recurring revenue focus - TradingView
MYO: Recurring revenue and expanded payer coverage fuel growth and improved financial outlook - TradingView
MYO: Recurring revenue and expanded coverage drive growth, with 2026 revenue guided at $43–$46 million - TradingView
Myomo reiterates $40M–$42M 2025 revenue target as O&P channel, MyoConnect drive growth - MSN
Myomo director Kirk Thomas F buys $68,242 in company stock By Investing.com - Investing.com Nigeria
Myomo (MYO) director adds 75,006 shares through open‑market buying - Stock Titan
Myomo director Kirk Thomas F buys $68,242 in company stock - Investing.com
Myomo | 4: Statement of changes in beneficial ownership of securities-Director KIRK THOMAS F - Moomoo
Myomo director Manko Jr. acquires $173,907 in MYO stock By Investing.com - Investing.com South Africa
Horton Capital (MYO) reports 6% Myomo stake, wins board role and pushes declassification - Stock Titan
Myomo director Manko Jr. acquires $173,907 in MYO stock - Investing.com
Director-linked Horton Capital fund boosts Myomo (NYSE: MYO) stake with open-market buys - Stock Titan
MYOMO (MYO) director Joseph M. Manko Jr. reports 2.1M-share indirect stake - Stock Titan
MYO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MYO SEC FilingsMyomo 10-K, 10-Q, 8-K Forms - Stock Titan
Myomo (MYO) CCO sells 90,231 shares, retaining 109,478-share stake - Stock Titan
H.C. Wainwright Maintains Myomo(MYO.US) With Buy Rating, Maintains Target Price $5 - Moomoo
MYO (NYSE) Form 144: Broker lists 90,231 restricted shares for resale - Stock Titan
Myomo Appoints Joseph M. Manko to Board - Moomoo
Myomo Adds Horton Capital Executive to Board of Directors - The Globe and Mail
[ARS] MYOMO, INC. SEC Filing - Stock Titan
Myomo Announces Participation in Upcoming Investor Conferences - The Joplin Globe
Myomo (NYSE: MYO) 2026 proxy targets share increase, equity plan and declassified board vote - Stock Titan
Safeguard Scientifics stock (US78437J1007): Myomo appoints Safeguard director to board - AD HOC NEWS
Myomo appoints Joseph M. Manko to its board - Medical Buyer
Here is why bargain hunters would love fast-paced mover Myomo (MYO) - MSN
Myomo appoints Joseph Manko to board of directors By Investing.com - Investing.com Australia
Earnings call transcript: Myomo beats Q1 2026 expectations, stock dips - Investing.com
Earnings call transcript: Myomo beats Q1 2026 expectations, stock dips By Investing.com - Investing.com Nigeria
Myomo appoints Joseph Manko to board of directors - Investing.com UK
Myomo Appoints Joseph M. Manko to its Board of Directors - 01net
Myomo appoints Joseph M. Manko to its board of directors - marketscreener.com
Myomo Appoints Joseph M. Manko To Its Board Of Directors - TradingView
Joseph M. Manko joins Myomo (MYO) board, expanding it to seven directors - Stock Titan
Myomo, Inc. Appoints Joseph M. Manko Jr. as Director, Effective May 9, 2026 - marketscreener.com
TradingKey - tradingkey.com
Here Is Why Bargain Hunters Would Love Fast-paced Mover Myomo (MYO) - Yahoo Finance
Myomo Inc (MYO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.59%
1.94%
자본화:
|
볼륨(24시간):